NEULANDLAB - IntraDay Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

IntraDay Trade Rating: 3.7

📊 Intraday Trading Analysis for NEULANDLAB

NEULANDLAB offers a moderately favorable setup for intraday trading today. While technical indicators are bullish and the stock is trending above key moving averages, weak volume and a sharp decline in quarterly profit temper the conviction.

✅ Bullish Indicators

Technical Momentum

RSI (58.1): In bullish territory, with room to rise.

MACD (445): Strong positive momentum signal.

Price > 50-DMA (₹12,867) & 200-DMA (₹12,213): Uptrend confirmed.

Valuation & Fundamentals

EPS ₹203: Strong earnings base.

PEG Ratio (1.80): Reasonable for a growth stock.

ROCE (18.7%) & ROE (14.8%): Solid efficiency.

Debt-to-Equity (0.10): Very low leverage.

DII Holding ↑ (+0.60%): Domestic institutional support.

⚠️ Cautionary Signals

P/E (85.3) vs Industry PE (34.0): Rich valuation.

Qtr Profit Decline (-58.8%): Significant earnings contraction.

FII Holding ↓ (-0.43%): Foreign investor pullback.

Volume (45K) < Avg Vol (49K): Slightly below average — needs confirmation.

Dividend Yield (0.09%): Minimal income support.

🔹 Intraday Strategy

📌 If Entering Fresh Today

Optimal Buy Price: ₹13,750–₹13,800 (on dip near support)

Profit-Taking Levels

Target 1: ₹14,000 (minor resistance)

Target 2: ₹14,150 (if volume improves midday)

Stop-Loss: ₹13,600 (below 50-DMA and psychological support)

📌 If Already Holding Today

Exit Triggers

RSI drops below 55: Indicates momentum fading

MACD flattens or turns negative

Price fails to hold above ₹13,850–₹13,900 by mid-session

Volume remains weak or declines further

🧠 Final Thoughts

NEULANDLAB is a reasonable intraday candidate today, especially for momentum scalping. However, the recent earnings drop and low volume suggest caution. Use tight risk controls and monitor price action closely.

Would you like a comparison with other pharma stocks showing stronger earnings and volume setups?

Edit in a page